![Richard Schoenfeld](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Richard Schoenfeld
Former positions of Richard Schoenfeld
Companies | Position | Start | End |
---|---|---|---|
PharmAthene, Inc. /Old/
![]() PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Chief Operating Officer | 2005-09-30 | 2007-08-08 |
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Corporate Officer/Principal | - | - |
Training of Richard Schoenfeld
Northeastern University | Undergraduate Degree |
St. Louis University | Masters Business Admin |
Statistics
International
United States | 5 |
Spain | 2 |
Operational
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
PharmAthene, Inc. /Old/
![]() PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Health Technology |
Polytechnic University | Consumer Services |
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
- Stock Market
- Insiders
- Richard Schoenfeld
- Experience